FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely xylometazoline 500 microgram/1 milliliter conventional release nasal spray (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Betamethasone 500 microgram orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Betamethasone 500 microgram orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Promazine 2.5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Promazine 2.5 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely prednisolone 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Sulfacetamide sodium 100 mg/g eye ointment Has concentration strength denominator value False un Inferred relationship Some 1
Sulfacetamide sodium 100 mg/g eye ointment Count of base of active ingredient False un Inferred relationship Some
Estradiol 2.5 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
Estradiol 2.5 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
Triamcinolone diacetate 25 mg/mL suspension for injection Has concentration strength denominator value False un Inferred relationship Some 1
Triamcinolone diacetate 25 mg/mL suspension for injection Count of base of active ingredient False un Inferred relationship Some
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely promazine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely promazine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Dibucaine 1 mg and prednisolone (as prednisolone sodium phosphate) 1.3 mg rectal suppository Has presentation strength denominator value False un Inferred relationship Some 1
Dibucaine 1 mg and prednisolone (as prednisolone sodium phosphate) 1.3 mg rectal suppository Has presentation strength denominator value False un Inferred relationship Some 2
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet Count of base of active ingredient False un Inferred relationship Some
Product containing precisely methylprednisolone 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely methylprednisolone 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 3
Bupivacaine hydrochloride 1.05 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Bupivacaine hydrochloride 1.05 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 3
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely thioridazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely thioridazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Esmolol hydrochloride 250 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Esmolol hydrochloride 250 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ketotifen 200 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ketotifen 200 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely salbutamol (as salbutamol sulfate) 2.5 milligram/1 actuation conventional release solution for inhalation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Sulfisoxazole 100 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
Sulfisoxazole 100 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ergometrine 200 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ergometrine 200 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment Count of base of active ingredient False un Inferred relationship Some
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Hydralazine hydrochloride 20 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Hydralazine hydrochloride 20 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Sulfacetamide sodium 200 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Sulfacetamide sodium 200 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet Has presentation strength denominator value False un Inferred relationship Some 1
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet Has presentation strength denominator value False un Inferred relationship Some 2
Dyphylline 6.67 mg/mL and guaifenesin 6.67 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Dyphylline 6.67 mg/mL and guaifenesin 6.67 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution Count of base of active ingredient False un Inferred relationship Some
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
Eflornithine (as eflornithine hydrochloride) 139 mg/mL cutaneous cream Count of base of active ingredient False un Inferred relationship Some
Eflornithine (as eflornithine hydrochloride) 139 mg/mL cutaneous cream Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely bupivacaine hydrochloride 7.5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely bupivacaine hydrochloride 7.5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
Estradiol 3.13 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
Estradiol 3.13 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
Sulfacetamide sodium 60 mg/g eye ointment Has concentration strength denominator value False un Inferred relationship Some 1
Sulfacetamide sodium 60 mg/g eye ointment Count of base of active ingredient False un Inferred relationship Some

Start Previous Page 86 of 217 Next End


This concept is not in any reference sets

Back to Start